221 related articles for article (PubMed ID: 11480143)
21. Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis). The effect of clofazimine therapy.
Baranda L; Torres-Alvarez B; Cortes-Franco R; Moncada B; Portales-Perez DP; Gonzalez-Amaro R
Arch Dermatol; 1997 Mar; 133(3):325-9. PubMed ID: 9080892
[TBL] [Abstract][Full Text] [Related]
22. Improvement of erythema dyschromicum perstans using a combination of the 1,550-nm erbium-doped fractionated laser and topical tacrolimus ointment.
Wolfshohl JA; Geddes ER; Stout AB; Friedman PM
Lasers Surg Med; 2017 Jan; 49(1):60-62. PubMed ID: 27552666
[TBL] [Abstract][Full Text] [Related]
23. Periorbital hyperpigmentation and erythema dyschromicum perstans.
Ing EB; Buncic JR; Weiser BA; de Nanassy J; Boxall L
Can J Ophthalmol; 1992 Dec; 27(7):353-5. PubMed ID: 1490247
[TBL] [Abstract][Full Text] [Related]
24. [Erythema dyschromicum perstans (ashy dermatosis)].
Kapu E; Daróczy J; Walcz E
Orv Hetil; 1984 Sep; 125(37):2245-9. PubMed ID: 6483412
[No Abstract] [Full Text] [Related]
25. [Erythema dyschromicum perstans].
Sebbag N; Lacour JP
Ann Dermatol Venereol; 2006 Jan; 133(1):79-82. PubMed ID: 16495863
[No Abstract] [Full Text] [Related]
26. Erythema dyschromicum perstans: the continuing enigma of Cinderella or ashy dermatosis.
Schwartz RA
Int J Dermatol; 2004 Mar; 43(3):230-2. PubMed ID: 15009400
[No Abstract] [Full Text] [Related]
27. Erythema dyschromicum perstans in phototype II women: three unusual clinical cases studied with electron microscopy.
Persechino S; Caperchi C; Cortesi G; Persechino F; Raffa S; Pulcini F; Tammaro A; Torrisi MR
Eur J Dermatol; 2011; 21(2):261-2. PubMed ID: 21382781
[No Abstract] [Full Text] [Related]
28. [Persistent dyschromic erythema].
Poljacki M; Duran V; Vucković N; Subotić M; Ivkov M; Matić M; Jovanović M
Med Pregl; 1999; 52(3-5):165-8. PubMed ID: 10518404
[TBL] [Abstract][Full Text] [Related]
29. Erythema dyschromicum perstans. A follow-up study from northern Finand.
Palatsi R
Dermatologica; 1977; 155(1):40-4. PubMed ID: 913745
[TBL] [Abstract][Full Text] [Related]
30. [Dermatosis cinecienta. A clinico-pathological study of 20 patients (1989-1990)].
Domínguez Soto L; Vega Memije ME; Arenas R; Waxtein Morgenstein L
Gac Med Mex; 1992; 128(6):623-7; discussion 627-8. PubMed ID: 1344798
[TBL] [Abstract][Full Text] [Related]
31. Erythema dyschromicum perstans/ashy dermatosis--a report of eight cases from Singapore.
Phay KL; Goh CL
J Dermatol; 1987 Oct; 14(5):502-5. PubMed ID: 3325541
[No Abstract] [Full Text] [Related]
32. [Current status of ashy dermatosis. Synonym--erythema dyschromicum perstans].
Ramirez O; Lopez Lino DG
Med Cutan Ibero Lat Am; 1984; 12(1):11-8. PubMed ID: 6376975
[TBL] [Abstract][Full Text] [Related]
33. [Chronic toxic erythemo-macular skin hyperpigmentation (erythema dyschromicum perstans, ashy dermatosis].
Samos-Zielińska J; Lańcucki J; Dabrowski J; Sadowska-Iwańciow H
Przegl Dermatol; 1979; 66(4):385-91. PubMed ID: 493562
[No Abstract] [Full Text] [Related]
34. [Erythema dyschromicum perstans-ashy dermatosis (EDP-AD). Clinical aspects and problems of classification].
Rotoli M; Stefanato CM; Rezza E
G Ital Dermatol Venereol; 1987 Mar; 122(3):119-20. PubMed ID: 3596645
[No Abstract] [Full Text] [Related]
35. Case for diagnosis.
Cherobin AC; Oliveira FO; Baeta IG; Vale EC
An Bras Dermatol; 2012; 87(1):151-2. PubMed ID: 22481670
[TBL] [Abstract][Full Text] [Related]
36. Erythema dyschromicum perstans in early childhood.
Lee SJ; Chung KY
J Dermatol; 1999 Feb; 26(2):119-21. PubMed ID: 10091483
[TBL] [Abstract][Full Text] [Related]
37. [Idiopathic eruptive macular pigmentation (author's transl)].
Degos R; Civatte J; Belaïch S
Ann Dermatol Venereol; 1978 Feb; 105(2):177-82. PubMed ID: 677686
[TBL] [Abstract][Full Text] [Related]
38. HLA-DR association with the genetic susceptibility to develop ashy dermatosis in Mexican Mestizo patients.
Correa MC; Memije EV; Vargas-Alarcón G; Guzmán RA; Rosetti F; Acuña-Alonzo V; Martínez-Rodríguez N; Granados J
J Am Acad Dermatol; 2007 Apr; 56(4):617-20. PubMed ID: 17116345
[TBL] [Abstract][Full Text] [Related]
39. [Macular idiopathic pigmentation (erythema dyschromicum perstans)].
Karalitskiĭ EM; Khmelevskiĭ AD
Vestn Dermatol Venerol; 1984 Feb; (2):49-51. PubMed ID: 6720074
[No Abstract] [Full Text] [Related]
40. Coexistence of erythema dyschromicum perstans and vitiligo: a case report and review of the literature.
Tamer F
Acta Dermatovenerol Alp Pannonica Adriat; 2016 Dec; 25(4):77-78. PubMed ID: 28006880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
